CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Ovaprenedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03598088
NCT03598088N/ACompleted
CompareCT.gov

Safety and Acceptability Study of a Non-Hormonal Ring

Daré Bioscience, Inc.·interventional·Posted Jul 26, 2018·Updated Jun 8, 2022

In Brief

A clinical study evaluating Ovaprene for Contraception. Completed, enrolled 38 participants across 6 sites.

Detailed Summary

This is a feasibility, multi-center, open-label, non-significant risk device study for a non-hormonal contraceptive ring.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartMay 23, 2018
Primary CompletionOct 17, 2019
Study CompletionNov 15, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.9 years ago

Interventions

Ovaprenedevice

non-hormonal contraceptive ring